TNF-α was found to have 100% specificity and sensitivity in distinguishing breast cancer patients with metastases from patients without metastasis (when the cut-off value is selected as 12.33 pg/mL), and high-grade patients from low-intermediate grade patients (when the cutoff value is selected as 12.01 pg/mL). This evidence concerns the gene TNF and breast carcinoma.